Related Experiment Video
Updated: Oct 11, 2025
11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
695
Comprehensive Metabolomics Study in Children With Graves' Disease
Qin Xia1, Weifeng Qian2, Linqi Chen1
1Department of Endocrinology, Genetics and Metabolism, Children's Hospital of Soochow University, Suzhou, China.
Frontiers in Endocrinology
|December 6, 2021
Summary
Graves' disease in children significantly alters serum metabolites, impacting amino acid and purine pathways. This study reveals key metabolic changes for better understanding hyperthyroidism in pediatric patients.
Area of Science:
- Pediatric Endocrinology
- Metabolomics
- Biochemistry
Background:
- Graves' disease (GD) causes hyperthyroidism (HT), affecting metabolism and energy balance.
- Understanding metabolic alterations in children with GD is crucial for clinical management.
Purpose of the Study:
- To comprehensively analyze metabolic changes in children with newly diagnosed Graves' disease.
- To investigate the clinical relevance of these metabolic alterations.
Main Methods:
- Serum samples from 30 children with GD and 30 healthy controls were analyzed.
- Untargeted metabolomics was performed using ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS).
- Multivariate statistical analysis was used to interpret metabolomic data.
Main Results:
- A total of 730 metabolites were identified, with 48 showing significant differences between GD and control groups.
- GD patients exhibited altered levels of amino acids, dipeptides, lipids, and purines.
- Pathway analysis indicated significant impacts on aminoacyl-tRNA biosynthesis, amino acid, purine, and pyrimidine metabolism.
Conclusions:
- Untargeted metabolomics revealed significant variations in serum metabolic patterns in children with Graves' disease.
- These findings highlight the profound metabolic impact of hyperthyroidism in pediatric GD.
- Further research can explore the clinical utility of these identified biomarkers.
More Related Videos
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
27
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
01:20Inborn Errors of Metabolism
301
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
301
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
19
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
01:20Synthesis and Regulation of Thyroid Hormones
5.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.5K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
10
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
10